IL122815A0 - Oxazolidinone derivatives process for preparing the same and medicaments that contain these compounds - Google Patents

Oxazolidinone derivatives process for preparing the same and medicaments that contain these compounds

Info

Publication number
IL122815A0
IL122815A0 IL12281596A IL12281596A IL122815A0 IL 122815 A0 IL122815 A0 IL 122815A0 IL 12281596 A IL12281596 A IL 12281596A IL 12281596 A IL12281596 A IL 12281596A IL 122815 A0 IL122815 A0 IL 122815A0
Authority
IL
Israel
Prior art keywords
medicaments
preparing
compounds
contain
same
Prior art date
Application number
IL12281596A
Other languages
English (en)
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of IL122815A0 publication Critical patent/IL122815A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
IL12281596A 1995-07-07 1996-07-04 Oxazolidinone derivatives process for preparing the same and medicaments that contain these compounds IL122815A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19524765A DE19524765A1 (de) 1995-07-07 1995-07-07 Neue Oxazolidinonderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
PCT/EP1996/002939 WO1997003072A1 (de) 1995-07-07 1996-07-04 Neue oxazolidinonderivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
IL122815A0 true IL122815A0 (en) 1998-08-16

Family

ID=7766252

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12281596A IL122815A0 (en) 1995-07-07 1996-07-04 Oxazolidinone derivatives process for preparing the same and medicaments that contain these compounds

Country Status (19)

Country Link
US (1) US5972947A (xx)
EP (1) EP0839147A1 (xx)
JP (1) JPH11508904A (xx)
KR (1) KR19990028792A (xx)
CN (1) CN1195348A (xx)
AU (1) AU709208B2 (xx)
BR (1) BR9609327A (xx)
CA (1) CA2225411A1 (xx)
CZ (1) CZ288619B6 (xx)
DE (1) DE19524765A1 (xx)
HU (1) HUP9900348A3 (xx)
IL (1) IL122815A0 (xx)
NO (1) NO310194B1 (xx)
NZ (1) NZ313599A (xx)
PL (1) PL324436A1 (xx)
SK (1) SK298A3 (xx)
TW (1) TW332206B (xx)
WO (1) WO1997003072A1 (xx)
ZA (1) ZA965712B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9901741A3 (en) * 1996-03-30 2000-03-28 Roche Diagnostics Gmbh Novel oxazolidine derivatives, process for their production and medicaments containing them
AR012443A1 (es) * 1997-04-16 2000-10-18 Uriach & Cia Sa J Nuevas carboxamidas como inhibidores de la agregacion plaquetaria, procedimiento para su preparacion, composiciones farmaceuticas que loscontienen y uso de los mismos en la manufactura de medicamentos
AR013693A1 (es) * 1997-10-23 2001-01-10 Uriach & Cia Sa J Nuevas piperidinas y piperazinas como inhibidores de la agregacion plaquetaria
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
AU2003235895A1 (en) * 2002-05-09 2003-11-11 Mochida Pharmaceutical Co., Ltd. Process for producing 1-(4-pyridyl)-4-piperidone
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
EP1805165B1 (en) * 2004-10-18 2009-12-16 Eli Lilly And Company 1-(hetero)aryl-3-amino-pyrrolidine derivatives for use as mglur3 receptor antagonists
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
EP1934208B1 (de) 2005-10-04 2011-03-23 Bayer Schering Pharma Aktiengesellschaft Neue polymorphe form von 5-chlor-n-({ ( 5s )-2-0x0-3-[4-( 3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl} -methyl)-2-thiophencarboxamid
DE102005048824A1 (de) * 2005-10-10 2007-04-12 Bayer Healthcare Ag Behandlung und Prophylaxe von Mikroangiopathien
DE102006051625A1 (de) * 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
DE102007018662A1 (de) 2007-04-20 2008-10-23 Bayer Healthcare Ag Oxazolidinone zur Behandlung und Prophylaxe von pulmonaler Hypertonie
DE102007028318A1 (de) 2007-06-20 2008-12-24 Bayer Healthcare Ag Oxazolidinone zur Behandlung und Prophylaxe von Sepsis
EP2138178A1 (en) 2008-06-28 2009-12-30 Bayer Schering Pharma Aktiengesellschaft Oxazolidninones for the treatment fo chronic obstructive pulmonary disease (COPD) and/or asthma
EP2140866A1 (en) 2008-07-04 2010-01-06 Bayer Schering Pharma Aktiengesellschaft Oxazolidinones for the treatment of inflammatory conditions of the gastrointestinal tract
WO2014085413A1 (en) * 2012-11-28 2014-06-05 Temple University - Of The Commonwealth System Of Higher Education Disubstituted oxazolidin-2-ones 5-hydroxytryptamine receptor 2b activity modulators
CN105829304B (zh) * 2013-12-20 2019-09-20 中国人民解放军军事医学科学院毒物药物研究所 N,n’取代哌啶胺类化合物、其制备方法及用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9122016D0 (en) * 1991-10-16 1991-11-27 Glaxo Group Ltd Chemical compounds
WO1993014077A1 (en) * 1992-01-21 1993-07-22 Glaxo Group Limited Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
PT825184E (pt) * 1993-03-29 2001-11-30 Astrazeneca Ab Derivados heterociclicos como inibidores de agregacao de plaquetas
DK0623615T3 (da) * 1993-05-01 1999-12-13 Merck Patent Gmbh Adhæsionsreceptor-antagonister
DE4324393A1 (de) * 1993-07-21 1995-01-26 Merck Patent Gmbh 4-Aryloxy- und 4-Arylthiopiperidinderivate
DE4332384A1 (de) * 1993-09-23 1995-03-30 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten III

Also Published As

Publication number Publication date
MX9800157A (es) 1998-03-29
KR19990028792A (ko) 1999-04-15
CA2225411A1 (en) 1997-01-30
NZ313599A (en) 1999-10-28
TW332206B (en) 1998-05-21
HUP9900348A2 (hu) 1999-05-28
CZ423397A3 (cs) 1998-03-18
US5972947A (en) 1999-10-26
ZA965712B (en) 1998-01-05
EP0839147A1 (de) 1998-05-06
CN1195348A (zh) 1998-10-07
JPH11508904A (ja) 1999-08-03
HUP9900348A3 (en) 2000-11-28
NO980059D0 (no) 1998-01-06
SK298A3 (en) 1998-05-06
PL324436A1 (en) 1998-05-25
WO1997003072A1 (de) 1997-01-30
DE19524765A1 (de) 1997-01-09
BR9609327A (pt) 1999-05-25
AU6611396A (en) 1997-02-10
NO980059L (no) 1998-01-06
CZ288619B6 (cs) 2001-08-15
NO310194B1 (no) 2001-06-05
AU709208B2 (en) 1999-08-26

Similar Documents

Publication Publication Date Title
US5756817C1 (en) O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same
IL122815A0 (en) Oxazolidinone derivatives process for preparing the same and medicaments that contain these compounds
IL117659A0 (en) Acetamide derivative process for preparing the same and a pharmaceutical composition containing the same
HUP9900625A3 (en) Benzimidazole derivatives, pharmaceutical compositions containing them and process for preparing the compounds
HUP9802565A3 (en) N-benzyl-dioxothiazolidinylmethyl-benzamide derivatives, pharmaceutical compositions containing them and process for producing the same
HUP9702534A3 (en) Propiophenone derivatives, process for preparing them and medicaments containing the said compounds
IL116315A0 (en) Process for preparing polyethylene
IL113084A0 (en) Thiazolidine and oxazolidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HUT72308A (en) Thiazolidine derivatives and pharmaceutical composition containing the same, and process for their preparation
ZA962916B (en) New arylglycineamide derivatives processes for the manufacture thereof and pharmaceutical compositions containing these compounds
HUP9901485A3 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
ZA969220B (en) Nucleoside derivatives and process for preparing the same
HUP9903902A3 (en) Bromotiacumicin compounds, process for producing them and medicaments containing the same
HU9602763D0 (en) Novel isoxazole derivatives, process for producing them and pharmaceutical compositions containing the same
HRP931016A2 (en) Thienothiazin derivatives, process for the preparation and application thereof
EP0693485A3 (en) Baccatin derivatives and methods of preparing them
HUP9600173A3 (en) 4-amino-benzoyl-guanidine derivatives, process for preparing them and pharmaceutical compositions containing them
HUP9903696A2 (en) 5-naphthalen-1-yl-1,3-dioxane derivatives, medicaments containing the same and process for producing them
HU914075D0 (en) Thia-diazinone derivatives, process for producing them and pharmaceutical preparatives containing said compounds
HK1001395A1 (en) 6-methoxy-1h-benzotriazole-5-carboxamide derivatives, process for producing the same, and medicinal composition containing the same
GB2302691B (en) Oxaindene derivatives and process for the preparation thereof
IL115907A0 (en) Process for the preparation of 1-halo-3-trialkylsilanyl-benzene derivatives
HU9401281D0 (en) Heterocyclic compounds, pharmaceutical compositions containing them, and process for producing the active components
HUP9903272A3 (en) Oxazolidinone compounds and process for the preparation thereof
GB9424890D0 (en) Process for preparing pyrolizine derivatives